Todd Campbell, TheStreet's co-editor-in-chief, a 30-year Wall Street veteran and former Series 7/65 licensed advisor, ...
Puma Biotechnology (PBYI) relies on one product. It has weak fundamentals and has struggled to grow sales. ・PBYI stock has ...